Ann Thorac Surg 2001;71:S183-S184
© 2001 The Society of Thoracic Surgeons
Presented at the Fifth International Conference on Circulatory Support Devices for Severe Cardiac Failure, New York, NY, Sept 1517, 2000.
DR J. DONALD HILL (San Francisco, CA):
I have a question for Laman Gray and Bill Pierce. The total heart is on its way. And since you began this work many years ago, many more things have happened. I was wondering what class of patients you are anticipating to use the total heart on?
DR LAMAN A. GRAY, JR (Louisville, KY):
The initial group of patients who will be candidates for a total artificial heart will be patients who are not transplant candidates and who have end-stage cardiomyopathy with a life expectancy of less than 30 days. There will be no alternative therapies for this group of patients.
But what about in terms of alternatives to other devices, you would see it crossing the line?
Initially the total artificial heart will be used in patients with biventricular failure rather than left ventricular failure. There are currently no other permanent implantable devices that can treat biventricular failure.
DR WILLIAM S. PIERCE
|HOME||HELP||FEEDBACK||SUBSCRIPTIONS||ARCHIVE||SEARCH||TABLE OF CONTENTS|
|ANN THORAC SURG||ASIAN CARDIOVASC THORAC ANN||EUR J CARDIOTHORAC SURG|
|J THORAC CARDIOVASC SURG||ICVTS||ALL CTSNet JOURNALS|